Effectiveness of Mass Drug Administration for Reducing Seasonal Malaria Transmission in Zanzibar (MaDrAZ)
Effectiveness of Mass Drug Administration (MDA) for Reducing Seasonal Malaria Transmission Towards Its Elimination in Hotspot Areas in Zanzibar - a Cluster-randomised Controlled Trial
Sponsor: Mahidol Oxford Tropical Medicine Research Unit
This NA trial investigates Malaria and Plasmodium Infections and is currently completed. Mahidol Oxford Tropical Medicine Research Unit leads this study, which shows 9 recorded versions since 2016 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Sep 2020 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Sep 2020 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Mar 2017 — Oct 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Mar 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mahidol Oxford Tropical Medicine Research Unit
- RTI International
- The President's Malaria Initiative
- Ulrika Morris
- University of California, San Francisco
- Uppsala University
- Zanzibar Malaria Elimination Programme
For direct contact, visit the study record on ClinicalTrials.gov .